-
Global Momentum in Parkinson’s Disease Therapeutics: Ten-Year Trends in Mechanisms, Modalities, and Clinical Endpoints
-
Global Parkinson´s Symptoms Index Correlates with Changes in Quality of Life and Autonomy for Activities of Daily Living
-
Global Performance Patterns in the MDS-UPDRS Motor Certification Program: A five-year Analysis
-
Global Roles of Nurses and Advanced Practice Providers in Parkinson’s Disease Care: Findings from an International Workforce Survey
-
Global Trends in Parkinson’s Disease Research: A Bibliometric Snapshot (2021–2024)
-
Globus Pallidus Internus Deep Brain Stimulation for Dystonia in COX20-Related Mitochondrial Complex IV Deficiency (MC4DN11): First Reported Case
-
GLP-1 Receptor Agonists in Movement Disorders: From Parkinson’s Disease to the Broader Spectrum — Mechanisms, Evidence, and Future Directions
-
GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes
-
Glymphatic dysfunction in patients with Parkinson’s disease is associated with regional amygdala and putamen degeneration
-
Grey Matter Volume and White Matter Microstructural Alterations in PRKN-PD
- « Previous Page
- 1
- …
- 92
- 93
- 94
- 95
- 96
- …
- 208
- Next Page »
